Inventor
Ke Chen
Inventor
East Brunswick, NJ, US
Overview
Patents· 18 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds34%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations18%
C07CAcyclic or carbocyclic compounds16%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium14%
A61KPreparations for medical, dental or toiletry purposes6%
Y02PClimate change mitigation technologies in the production or processing of goods4%
A61BDiagnosis2%
A61FFilters implantable into blood vessels2%
A61LMethods or apparatus for sterilising materials or objects in general2%
C08LCompositions of macromolecular compounds2%
PatentTitleYear
10,450,274Quinoline compounds, preparation methods thereof, and uses thereof as urate transporter inhibitor drug201910,219,794Method of treating pleural abnormality20199,403,821'Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound'20169,394,322'Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound'20169,376,458'Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound'20169,273,067'Pyrazolopyrimidine macrocycles as inhibitors of human immunodeficiency virus replication'20169,255,113'Methods for the Preparation of HIV attachment inhibitor piperazine prodrug compound'20169,249,168'Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound'20169,243,010'Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound'20168,889,869'Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound'20147,795,290'2-amido-thiazole-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof'20107,410,988'2-Amido-thiazole-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof'20087,026,339'Inhibitors of HCV NS5B polymerase'20066,683,181'Pyrroloquinolones as antiviral agents'20046,525,049'Pyrroloquinolones as antiviral agents'20036,229,016'Method for treating tumors using 2-aryl-naphthyridin-4-ones'20016,071,930'Method for treating tumors using 2-aryl-naphthyridin-4-ones'20005,994,367'Method for treating tumors using 2-aryl-naphthyridin-4-ones'1999Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1999–2001Patents assigned to UNIV NORTH CAROLINA (3)· patent assignee history
1999–2010Based in Chapel Hill, NC, US· patent location history
2003–2004Based in Kalamazoo, MI, US· patent location history
2006Patents assigned to ANDERSON REBECCA MERRY (1)· patent assignee history
2006Patents assigned to CHEN KE (1)· patent assignee history
2008–2010Patents assigned to GENENTECH INC (2)· patent assignee history
2014–2016Patents assigned to BRISTOL MYERS SQUIBB CO (8)· patent assignee history
2014–2016Based in East Brunswick, NJ, US· patent location history
2019Based in Sichuan, CN· patent location history
2019Based in Taipei, TW· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BRISTOL MYERS SQUIBB CO | 8 | 2014–2016 |
| UNIV NORTH CAROLINA | 3 | 1999–2001 |
| GENENTECH INC | 2 | 2008–2010 |
| ANDERSON REBECCA MERRY | 1 | 2006 |
| CHEN KEself | 1 | 2006 |
Locations
| Location | Patents | Span |
|---|---|---|
| East Brunswick, New Jersey, US | 8 | 2014–2016 |
| Chapel Hill, NC, US | 6 | 1999–2010 |
| Kalamazoo, MI, US | 2 | 2003–2004 |
| Sichuan, CN | 1 | 2019 |
| Taipei, TW | 1 | 2019 |